# A Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic Colorectal Cancer

> **NCT07050394** · EARLY_PHASE1 · RECRUITING · sponsor: **Shanghai Changzheng Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Colorectal Cancer Metastatic
- Colorectal Cancer Recurrent
- Colorectal Cancer Stage IV

## Interventions

- **DRUG:** CD-GA-102

## Key facts

- **NCT ID:** NCT07050394
- **Lead sponsor:** Shanghai Changzheng Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-10
- **Primary completion:** 2028-06
- **Final completion:** 2028-06
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07050394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07050394, "A Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07050394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*